Alpha Profiles · Company Profile
BeOne Medicines Ltd.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/beone-medicines-ltd
- Entity
- Public listing published
- Primary listing
- OTC: BEIGF
- Verification
- Partially verified
- Last reviewed
- 2026-10-16T13:54:58.592666+00:00
Overview
Alpha's canonical identity and public leadership record for BeOne Medicines Ltd..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
5 public recordsChief Financial Officer
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- BEIGF DEF 14A executive officersApr 28, 2026
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- BEIGF DEF 14A executive officersApr 28, 2026
Co-Founder, Chairman and Chief Executive Officer
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- BEIGF DEF 14A executive officersApr 28, 2026
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- BEIGF DEF 14A executive officersApr 28, 2026
President and Chief Operating Officer
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- BEIGF DEF 14A executive officersApr 28, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
11 public records- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2010
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2015
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2014
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2014
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
- State
- confirmed
- Effective
- From Jan 1, 2016
- Confidence
- 85%
- Evidence
- Onconova Therapeutics DEF 14A 2025-04-07Apr 7, 2025
Committees
3 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Shalini Sharp
- Members
- Shalini Sharp (Chair); Anthony C. Hooper; Corazon D. Sanders; Olivier Brandicourt
Compensation
- Chair
- Margaret Dugan
- Members
- Margaret Dugan (Chair); Qingqing Yi; Ranjeev Krishana
Nominating and Governance
- Chair
- Anthony C. Hooper
- Members
- Anthony C. Hooper (Chair); Alessandro Riva; Michael Goller; Shalini Sharp
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-16T13:54:58.592666+00:00